|
WO2013122446A1
|
|
Composition for preventing tachycardia during heart pain treatment
|
|
WO2013039367A1
|
|
Preparation that effectively reduces high glutamate level in blood
|
|
LV14212A
|
|
A device for measuring internal tissue pressure
|
|
LV14222A
|
|
Method of detection of effectiveness of treatment of chronic bronchitis
|
|
LV14171A
|
|
An agent for prevention of bone tissue resorption and atrophy after endoprosthetic surgery
|
|
LV14164A
|
|
Method of predicting the type of chronic lymphocytic leukemia
|
|
LV14131A
|
|
Method of prediction of avascular necrosis following talar neck fractures
|
|
LV14106A
|
|
An agent for treatment of children with juvenile idiopathic arthritis (jia)
|
|
LV14096A
|
|
Investigation method of central auditory disorders
|
|
LV14075A
|
|
An agent for restoration of sensibility of bronchical beta-receptors in patients with longterm resistant obstruction
|
|
LV14065A
|
|
Method of detection of effectiveness of treatment of chronice gastritis and reflux-oesophagitis
|
|
LV14044A
|
|
Method of evaluation of efficiency of treatment of disorders of mucosa of oral cavity and periodontal tussue
|
|
LV14074A
|
|
Agent for restoration of adrenocortical function
|
|
LV14031A
|
|
Cranberry and lingonberry tablets and method for producing thereof
|
|
LV14066A
|
|
Method of prognosing a risk of development of syndrome of systemic inflammatory reaction in newborns and children
|
|
LV14194A
|
|
Method of production of active pharmaceutical ingredient comprising natural lactoferrin
|
|
LV13888A
|
|
Composition containing viscous extract of coniferous needles for encapsulation
|
|
LV13939A
|
|
A method for detection of malignant tumors in native loose biopsy tissue material
|
|
LV13938A
|
|
A method for determination of quantitative volume of malignant tumors in native tissue material
|
|
LV13769B
|
|
Method for prediction of risk for development of intra-abdominal hypertension when patient is ill with acute pancreatitis
|
